Form 4: Elanco Executive Rajeev Modi Acquires Deferred Stock Units
Insider Transaction Report
Rajeev A. Modi, Executive Vice President at Elanco Animal Health Inc., acquired 105.2545 deferred stock units on May 30, 2025, increasing his beneficial ownership.
Summary
- Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc. (ELAN), reported a transaction on May 30, 2025.
- The transaction involved the acquisition of 105.2545 Deferred Stock Units (DSUs).
- Each DSU represents the right to receive one share of Company common stock or its cash equivalent.
- The DSUs were acquired at a price of $13.44 per unit.
- Following this transaction, Mr. Modi's beneficial ownership of derivative securities (DSUs) increased to 6,259.2621 units.
- These deferred stock units are set to settle in cash or shares of Company common stock upon termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.
Sentiment
Score: 7
Explanation: The sentiment is positive as an executive is increasing their beneficial ownership in the company, which typically signals confidence in future performance.
Positives
- The acquisition of additional deferred stock units by a key executive like Rajeev A. Modi can signal management's confidence in the company's future performance and long-term value.
- The increase in beneficial ownership aligns the executive's interests more closely with those of the shareholders.
Future Outlook
The document indicates that the deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year, aligning executive compensation with long-term company performance.
Management Comments
- Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation, acquired deferred stock units, reflecting participation in the company's Executive Deferral and Stock Match Plan.
Industry Context
This Form 4 filing is a routine disclosure of an insider's equity transaction and does not provide broader industry trends or competitive analysis. It reflects an individual executive's compensation and investment in the company.
Related Party Transactions
- The acquisition of deferred stock units is part of an executive compensation plan (Executive Deferral and Stock Match Plan), which is a common form of related-party transaction between a company and its executives.
Stakeholder Impact
- Shareholders may view this insider acquisition as a positive indicator of management's belief in the company's long-term value, potentially boosting investor confidence.
Next Steps
- Deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
Key Dates
| Date | Description |
|---|---|
| 05/30/2025 | Date of earliest transaction (acquisition of Deferred Stock Units). |
| 06/03/2025 | Date the Form 4 was signed and filed. |
Keywords
Elanco Animal Health, ELAN, Form 4, Insider Transaction, Deferred Stock Units, Executive Compensation, Beneficial Ownership, Rajeev Modi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.